Skip to main content
;

HESA Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

Previous day publication Next day publication

Minutes of Proceedings

42nd Parliament, 1st Session
Meeting No. 3
Monday, March 7, 2016, 3:30 p.m. to 5:40 p.m.
Video recorded session
Presiding
Bill Casey, Chair (Liberal)

• Tom Kmiec for Hon. K. Kellie Leitch (Conservative)
• Bryan May for John Oliver (Liberal)
Library of Parliament
• Karin Phillips, Analyst
Canadian Blood Services
• Dr. Dana Devine, Chief Medical and Scientific Officer
• Dr. Graham Sher, Chief Executive Officer
Public Health Agency of Canada
• Matthew Gilmour, Scientific Director General, National Microbiology Laboratory, Infectious Disease Prevention and Control Branch
• Dr. Gregory Taylor, Chief Public Health Officer
Pursuant to Standing Order 108(2) and the motion adopted on Wednesday, February 17, 2016, the Committee proceeded to a briefing session on the Zika virus outbreak.

Dr. Gregory Taylor and Dr. Graham Sher made statements and, with Matthew Gilmour and Dr. Dana Devine, answered questions.

At 5:01 p.m., the sitting was suspended.

At 5:11 p.m., the sitting resumed.

The Committee proceeded to the consideration of matters related to Committee business.

It was agreed, — That based on the evidence received by the Committee in relation to its briefing on the Zika Virus on March 7, 2016, the analysts prepare a Summary of Evidence.

The Chair presented the First Report from the Subcommittee on Agenda and Procedure which read as follows:

Your Subcommittee met on Monday, February 22, 2016 and recommends that the top priority items for the Committee be:

1. To undertake a study on the development of a national Pharmacare program as an insured service for Canadians under the Canada Health Act and to report the findings to the House;

2. To request a briefing from the Canadian Blood Services on the “Call to Action” report and on the status of Canada’s organ and tissue donation procurement system; and that the Minister of Health be requested to provide a response to the Committee on the findings of the “Call to Action” report and the actions taken to address the recommendations of the report;

3. To undertake a study on home care and palliative care and to report the findings to the House;

4. To undertake a study on the status of Aboriginal health and to report the findings to the House;

5. To undertake a study on the status of antibiotic resistance and to report the findings to the House.

Debate arose thereon.

After debate, it was agreed — That the First Report of the Subcommittee on Agenda and Procedure be concurred in.

It was agreed, — That, in relation to the study on the development of a national Pharmacare program as an insured service for Canadians under the Canada Health Act, the meeting of April 11, 2016, be dedicated to hearing officials from the Health Department; that six meetings be dedicated to the hearing of witnesses; and that the members of the Committee submit to the Clerk of the Committee, by Friday, March 11, 2016, their prioritized lists of witnesses.

At 5:40 p.m., the Committee adjourned to the call of the Chair.



David Gagnon
Clerk of the Committee